Jag Capital Management’s Guardant Health GH Stock Holding History

Jag Capital Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$615K	Buy	4,100 +138	+3%	+$15K	0.06%	77
2026 Q1	$366K	Sell	3,962 -998	-20%	-$100K	0.04%	103
2025 Q4	$507K	Buy	4,960 +987	+25%	+$88.3K	0.05%	81
2025 Q3	$248K	Buy	+3,973	New	+$216K	0.03%	117

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Jag Capital Management's GH Position: Q2 2026 in Review

Jag Capital Management increased its Guardant Health (GH) stake by 3.5% in Q2 2026, buying an estimated $15K and bringing the position to 4,100 shares worth $615K. The position accounts for 0.06% of the portfolio, ranked #77.

Jag Capital Management first reported a position in GH in Q3 2025 and has held it in 4 quarters since. 599 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Jag Capital Management held 4,100 shares of Guardant Health worth $615K as of Q2 2026.
Jag Capital Management bought 138 Guardant Health shares in Q2 2026, an estimated $15K.
Guardant Health made up 0.06% of Jag Capital Management's portfolio in Q2 2026, its #77 holding.
Jag Capital Management first reported a position in Guardant Health in Q3 2025 and has held it in 4 quarters since.
599 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Jag Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.